HIGH-VOLUME · HOSP-MID
insulin glargine Side Effects
insulin glargine (also sold as Lantus, Basaglar) is HIGH-VOLUME in this FAERS book #24 of 524 by FAERS report count. Signature opener: HOSP-MID - 26.6% mention hospitalization (62,916 reports).
Data updated 2026-05-15
- 236,147
- FAERS reports
FAERS voluntary reports, 2001 to 2025. High volume tracks exposure and reporting culture; see methodology for de-dup rules.
insulin glargine: 26.6% mention hospitalization (62,916 reports). Death stamp DEATH-HEAVY; volume band HIGH-VOLUME #24 of 524 by FAERS report count.
High-report extract for insulin glargine (Lantus): 236,147 FAERS rows (2001-2025). Top named reactions: BLOOD GLUCOSE INCREASED, BLOOD GLUCOSE DECREASED, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION. Outcome stamps DEATH-HEAVY · HOSP-MID · SEX-BALANCED. FAERS is voluntary signal detection, not incidence.
Counts from the openFDA FAERS extract (2001–2025). Stamps MEGA-CASE · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
BLOOD GLUCOSE INCREASED leads 38,214 of 236,147 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (57,639 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (13,233 reports, 5.6%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 4,520 |
| RENAL FAILURE | 834 |
| ACUTE KIDNEY INJURY | 657 |
| DYSPNOEA | 633 |
| MYOCARDIAL INFARCTION | 605 |
| PNEUMONIA | 600 |
| CARDIAC ARREST | 555 |
| SEPSIS | 546 |
| RESPIRATORY FAILURE | 416 |
| CHRONIC KIDNEY DISEASE | 415 |
| DIARRHOEA | 406 |
| NAUSEA | 403 |
| HYPOTENSION | 394 |
| ASTHENIA | 381 |
| ANAEMIA | 370 |
| FALL | 368 |
| CARDIAC FAILURE CONGESTIVE | 358 |
| HYPOGLYCAEMIA | 354 |
| CARDIO-RESPIRATORY ARREST | 349 |
| CEREBROVASCULAR ACCIDENT | 346 |
Reactions in Hospitalization Reports
Hospitalization mid-share (62,916, 26.6%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| BLOOD GLUCOSE INCREASED | 6,484 |
| HYPOGLYCAEMIA | 3,745 |
| FALL | 3,584 |
| DYSPNOEA | 3,460 |
| NAUSEA | 3,426 |
| PNEUMONIA | 3,306 |
| VOMITING | 3,207 |
| DIARRHOEA | 2,895 |
| ACUTE KIDNEY INJURY | 2,798 |
| ASTHENIA | 2,642 |
| FATIGUE | 2,498 |
| HYPERGLYCAEMIA | 2,477 |
| MALAISE | 2,329 |
| CEREBROVASCULAR ACCIDENT | 2,245 |
| BLOOD GLUCOSE DECREASED | 2,139 |
| DIABETIC KETOACIDOSIS | 2,133 |
| WEIGHT DECREASED | 2,046 |
| DIZZINESS | 2,002 |
| MYOCARDIAL INFARCTION | 1,993 |
| DEHYDRATION | 1,992 |
How to read insulin glargine FAERS figures (MEGA-CASE · DEATH-HEAVY · HOSP-MID)
FAERS holds 236,147 voluntary reports linked to insulin glargine (Lantus, Basaglar, Toujeo), 2001-2025. Death is listed on 13,233 (5.6%). Hospitalization appears on 62,916 (26.6%). Top co-reported indication: Type 2 Diabetes Mellitus.
MEGA-CASE books overweight common drugs and loud reporting cultures; HOSP-MID is the page opener, not a per-patient risk.
Read with insulin glargine
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-MID stamps.
ABS(total_reports) peer at 240,204 FAERS cases (Δ 4,057 heavier vs insulin glargine); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's MEGA-CASE · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 240,800 FAERS cases (Δ 4,653 heavier vs insulin glargine); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's MEGA-CASE · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 241,433 FAERS cases (Δ 5,286 heavier vs insulin glargine); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's MEGA-CASE · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 245,754 FAERS cases (Δ 9,607 heavier vs insulin glargine); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's MEGA-CASE · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 56.5 pp vs insulin glargine's DEATH-HEAVY): CASELOAD · HOSP-MID.
insulin glargine stamps DEATH-HEAVY · HOSP-MID; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload MEGA-CASE and the label guide.